Amarantus Bioscience Holdings Inc (AMBS)

[GS1]

The 70/70 is the standard right now and if Lympro can get it done without PET it is going to be standard. With PET they are getting in the 80s. They will need to fine tune some parameters to get into mid 80s. I'm sure you have seen Paula T's blog regarding this and they think they will be able to achieve this with some research. If they get closer to 85% they should be able to get CLIA approval. Life is not that easy everyone thought it would be but there is definitely hope for better diagnosis with Lympro. The waiting is the hardest part.

The pipeline is still good and nothing has changed significantly except PPS and that is due to conversion going on obviously. My only fear is that if Diogenix is converting it pps will suffer a lot.. I mean you are talking about 100 mil shares to be converted at .08 pre split pps and dilution will continue for longer period of time.